How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: An evidence-based review

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 5, 2011, Pages 297-302

  Vucinic, Violeta ^a,b   Skodric Trifunovic, Vesna ^a,b   Ignjatović, Svetlana ^b,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c School of Pharmacy   (Serbia)

Author keywords

Calcium metabolism; sarcoidosis; vitamin D

Indexed keywords

CALCITONIN; CALCIUM; CYTOKINE; PARATHYROID HORMONE; VITAMIN D;

ANTIGEN PRESENTATION; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EVIDENCE BASED MEDICINE; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; METABOLIC DISORDER; REVIEW; SARCOIDOSIS; TH1 CELL; VITAMIN D DEFICIENCY; VITAMIN METABOLISM;

CALCIUM METABOLISM DISORDERS; EVIDENCE-BASED MEDICINE; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; SARCOIDOSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80051748101     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328348b3cb     Document Type: Review

References (54)

1. 2 receptorpositive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis 2011;57:140-143.
2. Sharma OP. Renal sarcoidosis and hypercalcaemia. Eur Respir Mon 2005;32:220-232 (Printed in UK; ISSN 1025-448x. ISBN 1-904097-22-7).
3. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80:1689-1696.
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
5. Chung M, Balk EM. Vitamin D and calcium: a systematic review of health outcomes. Evidence Report/Technology Assessment Number 183. AHRQ Publication No. 09-E015. August 2009.
6. Townsend K, Evans KN, Campbell MJ, et al. Biological actions of extrarenal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005;97:103-109. (Pubitemid 41546219)
7. Norman AW. A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. Am J Clin Nutr 2008;88:1455-1456.
8. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009;94:26-34.
9. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008;76:3837-3843.
10. Mohr SB. A brief history of vitamin D and cancer prevention. Ann Epidemiol 2009;19:79-83.
11. Dawson-Hughes B. Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nutr 2008;88:537S-540S.
12. Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing 'D'ecline? Mol Aspects Med 2008;29:415-422.
13. Chu M, Alagiakrishnan K, Sadowski C. The cure of ageing: vitamin D: magic or myth? Postgrad Med J 2010;86:608-616.
14. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-1235.
15. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632.
16. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective. J Nutr 2005;135:310-316.
17. Conron M, Young C, Beyon H. Calcium metabolism in sarcoidosis and its clinical implications. Rheumatology 2000;39:707-713. (Pubitemid 30487892)
18. Mitchell T, Stamp T, Jenkins J. Hypercalcemic sarcoidosis in hypoparathyroidism. Br Med J 1983;1:764-765.
19. Karnchanasorn R, Sarikonda M, Aldasouqi S, Gossain VV. Severe hypercal-cemiaand acute renal failure: an unusual presentation of sarcoidosis. Hindawi Publishing Corporation Case Reports in Medicine. Volume 2010, Article ID 423659. doi:10.1155/2010/423659. The case report emphasizes the serious problem of severe hypercalcemia with renal failure in sarcoidosis; important experience for the clinicians.
20. Amrein K, Schilcher G, Fahrleitner-Pammer A. Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose. Letter to editors. Eur Respir J 2011;37:470-471.
21. Balasanthiran A, Sandler B, Amonoo-Kuofi K, Swamy R, et al. Sarcoid granulomas in the parathyroid gland: a case of dual pathology: hypercalcaemia due to a parathyroid adenoma and coexistent sarcoidosis with granulomas located within the parathyroid adenoma and thyroid gland. Endocrine J 2010;57:603-607. A case report about dual pathology; uncommon clinical appearance of hypercalcemia in sarcoidosis.
22. Chaychi L, Chaidarun S, Golding A, et al. Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvement. Endocr Pract 2010;16:463-467.
23. Adams J, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471-478.
24. Bhalla AK, Amento EP, Clemens TL, et al. Specific high-affinity receptors for 1, 25-dihydroxy vitamin D3 in human peripheral blood mononuclear cells, presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983;57:1308-1310. (Pubitemid 14209439)
25. Richmond B, Drake W. Vitamin D, innate immunity, and sarcoidosis granu-lomatous inflammation: insights from mycobacterial research. Curr Opin Pulm Med 2010;16:461-464. Review that sums up the existing knowledge of hypovitaminosis D as a risk factor for the development of sarcoidosis. The review also highlights recent studies showing the vitamin D-regulated, antimicrobial peptide cathelicidin to be important to the immune response against pathogenic mycobacteria, hypothesizing that cathelicidin could play a role in sarcoidosis pathogenesis.
26. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773;27.
27. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008;37:113-119. (Pubitemid 351228619)
28. Kanchwala AA, Barna BP, Singh RJ, et al. Deficiencies of cathelicidin and vitamin D accompany disease severity in sarcoidosis. Am J Respir Crit Care Med 2009;179:A3997.
29. Agerberth B, Grunewald J, Castanos-Velez E, et al. Antibacterial components in bronchioalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med 1999;160:283-290. (Pubitemid 29326101)
30. Provvedini D, Tsoukas C, Deftos I, et al. 1 a, 25-dihydroxy vitamin-D-binding molecules in human B-lymphocytes: effects on immunoglobulin production. J Immunol 1986;136:2734-2740. (Pubitemid 16107171)
31. Kavathia D, Buckley JD, Rao D, et al. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med 2010;104:564-570. The investigation that gives a completely new insight into possible prognosis of sarcoidosis. This is the first investigation that determines the relationship between serum 1, 25 (OH) D levels and the degree of sarcoidosis disease chronicity.
32. Prasse A, Katic C, Germann M, et al. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 2008;177:330-336. (Pubitemid 351198377)
33. Desai HV, Gandhi K, Sharma M, et al. Thiazide-induced severe hypercalcemia: a case report and review of literature. Am J Ther 2010;17:234-236. This study presents one of the most severe cases of thiazide-induced hypercalcemia, with a literature review of that topic. The authors highlight thus the problems of hypercalcemia from the scientific as well as clinical point of view.
34. James DG, Neville E, Siltzbach L, et al. A worldwide view of sarcoidosis. Ann N Y Acad Sci 1976;278:321-334.
35. Sharma O, Trowell J, Cohen N, et al. Abnormal calcium metabolism in sarcoidosis. In Turiaf J, Chabot J, editors. La Sarcoidose: Rapports de IV Conference Internationale (Proceedings of the IV International Conference on Sarcoidosis). Paris, Maison et Cie; 1967. pp. 627-631.
36. Monge M, Miquel O, Dugardin F, et al. Sarcoidosis and the kidney: not only the granulomatous interstitial nephritis. Clin Nephrol 2009;71:192-195.
37. Sharma O. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000;6:442-447. (Pubitemid 30637660)
38. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest 1996;109:535-539. (Pubitemid 26058615)
39. Rizzato G, Palmieri G, Agrati A, et al. The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:119-126. (Pubitemid 38954752)
40. Hamada H, Nagai S, Ono T, et al. Sarcoidosis complicated with IgA nephropathy. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:69-73. (Pubitemid 36559736)
41. Lower E. Renal sarcoidosis. In Baughman R, editor. Sarcoidosis. New York: Taylor & Francis; 2006. pp. 651.
42. Pathology. In James D, Williams W, editors. Sarcoidosis and other granulomatous disorders. Major problems in internal medicine. Vol. 24. New York, NY: W. B. Saunders Company; 1985. pp. 38-48.
43. Baughman R, Teirstein A, Judson M, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889. (Pubitemid 33152325)
44. Bergener R, Hoffman M, Waldherr R, et al. Frequency of kidney disease in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:118-125.
45. Sessa A, Meroni M, Battini G, et al. Acute renal failure due to idiopathic tubulointestinal nephritis and uveitis: TINU syndrome'. Case report and review of the literature. J Nephrol 2000;13:377.
46. Adams J, Gacad M. Characterisation of 1 alfa hydroxylation of vitamin D sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985;161:755-765. (Pubitemid 15083775)
47. Rizzato G. Clinical impact of bone and calcium metabolism changes in sarcoidosis. Thorax 1998;53:425-429. (Pubitemid 28261339)
48. Rizzato G. Calcium metabolism. In Baughman R, editor. Sarcoidosis. New York: Taylor & Francis; 2006. pp. 635-651.
49. Glass AR, Eil C. Ketoconazole induced reduction in serum 1, 25 dihydroxyvitamin D and total serum calcium in hypercalcemic patients. J Clin Endocrinol Metab 1988;66:934-938.
50. Adams J, Sharma O, Diz M, et al. Ketoconazole decreases the serum 1, 25 dihydroxyvitamin D and calcium concentration in sarcoidosis associated hypercalcemia. J Clin Endocrinol Metab 1990;70:1090-1095.
51. O'Leary TJ, Jones G, Yip A, et al. The effects of chloroquine on serum 1, 25 dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 1986;315:727-730. (Pubitemid 16054987)
52. Burke RR, Rybicki BA, Rao DS. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med 2010;31:474-484. The review highlights the immunomodulating properties of vitamin D with an emphasis on known interactions with sarcoidosis. The review assesses vitamin D nutritional status and the management of bone health impacted in several ways in patients with sarcoidosis.
53. Stechschulte SA, Kirsner RS, Federman DG. Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 2009;122:793-802.
54. Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. J Neurol 2006;253:464-470. (Pubitemid 43965611)